ArticleDiscover oncology2025

GRB10 as a pan-cancer biomarker linking oncogenic signaling, immunosuppression, and immunotherapy resistance.

Haoran Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.